Prevention and reversion of nonalcoholic steatohepatitis in OB/OB mice by S-nitroso-N-acetylcysteine treatment.
about
Herbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospectsNitric oxide regulates mitochondrial fatty acid metabolism through reversible protein S-nitrosylation.Structural profiling of endogenous S-nitrosocysteine residues reveals unique features that accommodate diverse mechanisms for protein S-nitrosylation.Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective.M1 polarization bias and subsequent nonalcoholic steatohepatitis progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1-induced oxidative stress in obese mice.Antioxidants as therapeutic agents for liver disease.Electron Therapy Attenuated Elevated Alanine Aminotransferase and Oxidative Stress Values in Type 2 Diabetes-Induced Nonalcoholic Steatohepatitis of Rats.Alcoholic liver disease and exacerbation by malnutrition and infections: what animal models are currently available?Apo-10'-lycopenoic acid, a lycopene metabolite, increases sirtuin 1 mRNA and protein levels and decreases hepatic fat accumulation in ob/ob mice.An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present.S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis.S-nitroso-N-acetylcysteine attenuates liver fibrosis in cirrhotic rats.
P2860
Q26828615-C044CC6F-A93B-4943-8536-B3436F3C1950Q33566513-0C1D763F-A9A9-4C1A-9714-AF0B6010DD6BQ34165669-E5253167-8D62-459C-945C-F9B0D39B5496Q34412650-976A6666-FE12-495D-A4A7-204C9904C912Q34785593-732C13AB-707C-4579-9234-85D974325C71Q35585469-097B04C3-FCCD-4CDD-A9FB-9A3027E98EB6Q36528728-4332F16E-7956-4DBD-A15F-3D7E2D7436C7Q37823647-86BCC757-58AB-4A2F-8FAD-E343072EEB08Q38328509-FA568693-AB20-4F07-B8E6-95C8BE005BCDQ38849996-14C0AC43-6B0A-461B-92F4-D6458FED4748Q43105330-000596F7-884E-4BBE-8B1B-AD78EDE37941Q43198035-C8DD2098-C1E9-42B3-B2F7-FEF766D66154
P2860
Prevention and reversion of nonalcoholic steatohepatitis in OB/OB mice by S-nitroso-N-acetylcysteine treatment.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Prevention and reversion of no ...... so-N-acetylcysteine treatment.
@ast
Prevention and reversion of no ...... so-N-acetylcysteine treatment.
@en
Prevention and reversion of no ...... so-N-acetylcysteine treatment.
@nl
type
label
Prevention and reversion of no ...... so-N-acetylcysteine treatment.
@ast
Prevention and reversion of no ...... so-N-acetylcysteine treatment.
@en
Prevention and reversion of no ...... so-N-acetylcysteine treatment.
@nl
prefLabel
Prevention and reversion of no ...... so-N-acetylcysteine treatment.
@ast
Prevention and reversion of no ...... so-N-acetylcysteine treatment.
@en
Prevention and reversion of no ...... so-N-acetylcysteine treatment.
@nl
P2093
P2860
P1476
Prevention and reversion of no ...... so-N-acetylcysteine treatment.
@en
P2093
Claudia P M S de Oliveira
Evandro S de Mello
Fernanda I Simplicio
Flair J Carrilho
Francisco G Soriano
Francisco R M Laurindo
Heraldo P de Souza
Marcelo G de Oliveira
Venâncio A F Alves
Vicência M R de Lima
P2860
P304
P356
10.1080/07315724.2008.10719703
P577
2008-04-01T00:00:00Z